{"nctId":"NCT02290925","briefTitle":"The Effect of Biscuit Containing Kothala Himbutu on Blood Glucose in Patients With Diabetes. A Randomized Control Study","startDateStruct":{"date":"2014-05"},"conditions":["Type 2 Diabetes Mellitus"],"count":133,"armGroups":[{"label":"Kothala Himbutu biscuit","type":"EXPERIMENTAL","interventionNames":["Drug: Kothala Himbutu Biscuit"]},{"label":"placebo biscuit","type":"PLACEBO_COMPARATOR","interventionNames":["Dietary Supplement: Placebo Biscuit"]}],"interventions":[{"name":"Kothala Himbutu Biscuit","otherNames":["Biscuit contining Salacia reticulata extract","Kothala Himbutu Biscuit manufactured by Ceylon Biscuits Ltd","Munchee Kothala Himbutu biscuit"]},{"name":"Placebo Biscuit","otherNames":["Biscuit","Munchee biscuit"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Type 2 diabetes for minimum period of 6 months\n2. Aged between 30 and 65 years\n3. Stable glycaemic control over the preceding 2-3 months. They will be initially selected from a range of HBA1C varying from 6.5 - 14 and the individual subject should not have a variation of \\>20% between the previous HBA1C and the HBA1C done at the commencement of the study\n\nExclusion Criteria:\n\n1. Chronic kidney disease with estimated Glomerular filtration rate less than 30ml/hour\n2. Severe valvular heart disease or heart failure.\n3. Those on Insulin therapy\n4. Severe liver disease (AST \\> 10 X times the upper limit)","healthyVolunteers":false,"sex":"ALL","minimumAge":"30 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Glycosylated Haemoglobin","description":"HBA1c were analyzed at a centrally accredited lab using ion exchange high performance liquid chromatography standardized to NGSP","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.36","spread":"0.19"},{"groupId":"OG001","value":"8.16","spread":"0.20"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.23","spread":"0.21"},{"groupId":"OG001","value":"8.53","spread":"0.21"}]}]}]},{"type":"SECONDARY","title":"Liver Adverse Effects","description":"liver functions are described in the table below with higher liver enzymes suggesting injury to the liver.","paramType":"MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null},{"groupId":"OG001","value":"37","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"39","spread":null},{"groupId":"OG001","value":"36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"37","spread":null},{"groupId":"OG001","value":"34","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28","spread":null},{"groupId":"OG001","value":"28","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28","spread":null},{"groupId":"OG001","value":"26","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null},{"groupId":"OG001","value":"24","spread":null}]}]}]},{"type":"SECONDARY","title":"Renal Adverse Effects -1","description":"Renal functions are described in the table below with Lower estimated Glomerular Filtration Rate (eGFR) suggesting injury to the kidney.","paramType":"MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"77.1","spread":null},{"groupId":"OG001","value":"76.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.0","spread":null},{"groupId":"OG001","value":"75.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"75.0","spread":null},{"groupId":"OG001","value":"76","spread":null}]}]}]},{"type":"SECONDARY","title":"Renal Adverse Effects - 2","description":"Renal functions are described in the table below with higher serum creatinine suggesting injury to the kidney.","paramType":"MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.94","spread":null},{"groupId":"OG001","value":"0.94","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.98","spread":null},{"groupId":"OG001","value":"0.96","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.97","spread":null},{"groupId":"OG001","value":"0.93","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":131},"commonTop":[]}}}